These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33436820)

  • 1. Identification of significantly mutated subnetworks in the breast cancer genome.
    Ajwad R; Domaratzki M; Liu Q; Feizi N; Hu P
    Sci Rep; 2021 Jan; 11(1):642. PubMed ID: 33436820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSNFS: Gene subnetwork biomarker identification of lung cancer expression data.
    Doungpan N; Engchuan W; Chan JH; Meechai A
    BMC Med Genomics; 2016 Dec; 9(Suppl 3):70. PubMed ID: 28117655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.
    Khunlertgit N; Yoon BJ
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):351. PubMed ID: 27766944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of mutated subnetworks associated with clinical data in cancer.
    Vandin F; Clay P; Upfal E; Raphael BJ
    Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.
    Hodzic E; Shrestha R; Zhu K; Cheng K; Collins CC; Cenk Sahinalp S
    Gigascience; 2019 Apr; 8(4):. PubMed ID: 30978274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
    Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical HotNet: identifying hierarchies of altered subnetworks.
    Reyna MA; Leiserson MDM; Raphael BJ
    Bioinformatics; 2018 Sep; 34(17):i972-i980. PubMed ID: 30423088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
    Guo L; Zhang K; Bing Z
    Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Efficient Algorithm for Identifying Mutated Subnetworks Associated with Survival in Cancer.
    Sarkar A; Atay Y; Erickson AL; Arisi I; Saltini C; Kahveci T
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1582-1594. PubMed ID: 30990435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
    Leiserson MD; Vandin F; Wu HT; Dobson JR; Eldridge JV; Thomas JL; Papoutsaki A; Kim Y; Niu B; McLellan M; Lawrence MS; Gonzalez-Perez A; Tamborero D; Cheng Y; Ryslik GA; Lopez-Bigas N; Getz G; Ding L; Raphael BJ
    Nat Genet; 2015 Feb; 47(2):106-14. PubMed ID: 25501392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Cancer Subtypes Using a Residual Graph Convolution Model on a Sample Similarity Network.
    Dai W; Yue W; Peng W; Fu X; Liu L; Liu L
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
    Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
    Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein interaction disruption in cancer.
    Ruffalo M; Bar-Joseph Z
    BMC Cancer; 2019 Apr; 19(1):370. PubMed ID: 31014259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.